Enable Injections Announces $215 Million Financing

Jan 27, 2022•over 3 years ago

Amount Raised

$215 Million

Cincinnati

Description

Enable Injections, Inc. ("Enable"), a company developing and manufacturing the enFuse® platform of investigational wearable drug delivery systems, is pleased to announce $215 million in Series C financing. Magnetar Capital ("Magnetar") led the financing along with new institutional investments from GCM Grosvenor, Squarepoint Capital, Woody Creek Capital Partners, and other investors. Enable received significant continued support from existing investors including Cincinnati Children's Hospital Medical Center, CincyTech, Cintrifuse, and Ohio Innovation Fund.

Company Information

Company

Enable Injections

Location

Cincinnati, Ohio, United States

About

Cincinnati-based Enable Injections is an investigational-stage company developing and manufacturing on-body subcutaneous drug delivery systems designed to improve the patient experience, support superior outcomes, and advance healthcare system value and economics. Enable's body-worn enFuse® drug delivery platform utilizes standard container closure systems to deliver high-volume pharmaceutical and biologic therapeutics. For more information, please visit www.enableinjections.com.

Funding Insights

Based on industry data

Tech investment trends

83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech